Perform Another (Advanced) Search

1.  Study Posting (4451) Trial #160984, Hair Loss, New York, NY
...Loss, New York, NY Trial Information HAIR LOSS STUDY Have you been diagnosed with androgenetic alopecia or are you experiencing visibly noticeable hair loss? If you are also a female between ...
View Page

2.  CenterWatch Clinical Research Profile (5174) Trial #2105, Advanced Dermatology & Cosmetic Surgery/Ameriderm Research, Ormond Beach, FL
...II-IV trials in the following therapeutic areas: • Acne • Actinic Keratoses • Advanced Basal Cell Carcinoma • Alopecia • Atopic Dermatitis • Basal Cell Carcinoma • Hand Dermatitis • Herpes Zoster • Onychomycosis • Osteoarthritis • Pediculosis Capitus • Psoriasis • Rosacea ...
...36 years of clinical research experience Phase II-IV • Acne • Actinic Keratosis • Adverse Drug Reaction • Alopecia • Atopic Dermatitis • Contact dermatitis • Cosmetic Dermatology • Head Lice • Herpes Zoster • Herpes Zoster, Herpes Simplex • Immunotherapy ...
View Page

3.  CenterWatch Clinical Research Profile (430) Trial #688, Radiant Research - Scottsdale, Scottsdale, AZ
...subjects in database : 30,000+ Regulatory submission : 3 business days Areas of Experience: • Allergic Rhinitis • Alopecia • Antimicrobials • Anxiety • Asthma • Atopic Dermatitis • Benign Prostatic Hyperplasia • Bronchitis - Chronic • Contraception • Coronary Artery Disease • Depression ...
...in the past nineteen years. Dr. Powers’s areas of expertise include: acne, actinic keratosis, alopecia, analgesic antagonist, atopic dermatitis, heartburn, herpes-genital, herpes-labialis, herpes-zoster, ichthyosis vulgaris, photodamaged skin ...
View Page

4. Clinical Trial Results by Drug Names
...combination therapy was as expected with these agents. The most frequent clinical adverse events were alopecia (93.3%), nausea (60.0%), mucositis (57.8%), asthenia (48.9%), pyrexia (48.9%), and ...
...moderate in intensity. The only Grade 3/4 treatment-related adverse events of note were alopecia (Grade 3, 44.4%; Grade 4, 2.2%) and neutropenia (Grade 3, 6.7%; Grade ...
View Page

5.  CenterWatch Clinical Research Profile (3596) Trial #1588, David Fivenson, MD, Dermatology, PLLC, Ann Arbor, MI
...ulcers • Foot ulcers • Baldness • Warts • Tinea/athlete's foot • Nail fungus • Cutaneous lymphoma • Blistering diseases • Alopecia areata • Nail fungus • Biologic therapies for psoriasis and psoriatic arthritis Facility Description Outpatient medical dermatology ...
View Page

6.  CenterWatch Clinical Industry Provider Profile(5379), Palm Beach CRO, West Palm Beach, FL
...active and have worked in the following clinical areas: • Cardiovascular (hypertension, angina, arrhythmias, CHF) • Dermatology (alopecia, eczema, psoriasis, seborrhea, omychomycosis) • Gastrointestinal (ulcerative colitis, IBS, GERD) • Skeletal (OA, RA) • Muscular (spasms) • CNS ...
View Page

7.  Study Posting (4259) Trial #87807, Lung Cancer, Sutton, Surrey, United Kingdom
...progressive disease; • Must have recovered from any treatment-related toxicities prior to registration, except for alopecia, grade 1 fatigue, or grade 1 neurotoxicity; • A current cigarette smoker (minimum of 10 cigarettes ...
View Page

8.  Study Posting (4259) Trial #87805, Lung Cancer, Sheffield, United Kingdom
...progressive disease; • Must have recovered from any treatment-related toxicities prior to registration, except for alopecia, grade 1 fatigue, or grade 1 neurotoxicity; • A current cigarette smoker (minimum of 10 cigarettes ...
View Page

9.  Study Posting (4259) Trial #87803, Lung Cancer, Newcastle upon Tyne, United Kingdom
...progressive disease; • Must have recovered from any treatment-related toxicities prior to registration, except for alopecia, grade 1 fatigue, or grade 1 neurotoxicity; • A current cigarette smoker (minimum of 10 cigarettes ...
View Page

10.  Study Posting (4259) Trial #87804, Lung Cancer, Glasgow, United Kingdom
...progressive disease; • Must have recovered from any treatment-related toxicities prior to registration, except for alopecia, grade 1 fatigue, or grade 1 neurotoxicity; • A current cigarette smoker (minimum of 10 cigarettes ...
View Page

11.  Study Posting (4259) Trial #87806, Lung Cancer, Dundee, United Kingdom
...progressive disease; • Must have recovered from any treatment-related toxicities prior to registration, except for alopecia, grade 1 fatigue, or grade 1 neurotoxicity; • A current cigarette smoker (minimum of 10 cigarettes ...
View Page

12.  Study Posting (4259) Trial #87801, Lung Cancer, Aberdeen, United Kingdom
...progressive disease; • Must have recovered from any treatment-related toxicities prior to registration, except for alopecia, grade 1 fatigue, or grade 1 neurotoxicity; • A current cigarette smoker (minimum of 10 cigarettes ...
View Page

13.  Study Posting (4259) Trial #87802, Lung Cancer, Edinburgh, Scotland
...progressive disease; • Must have recovered from any treatment-related toxicities prior to registration, except for alopecia, grade 1 fatigue, or grade 1 neurotoxicity; • A current cigarette smoker (minimum of 10 cigarettes ...
View Page

14.  Study Posting (4259) Trial #87797, Lung Cancer, Memphis, TN
...progressive disease; • Must have recovered from any treatment-related toxicities prior to registration, except for alopecia, grade 1 fatigue, or grade 1 neurotoxicity; • A current cigarette smoker (minimum of 10 cigarettes ...
View Page

15.  Study Posting (4259) Trial #87800, Lung Cancer, Winston-Salem, NC
...progressive disease; • Must have recovered from any treatment-related toxicities prior to registration, except for alopecia, grade 1 fatigue, or grade 1 neurotoxicity; • A current cigarette smoker (minimum of 10 cigarettes ...
View Page

16.  Study Posting (4259) Trial #87799, Lung Cancer, La Verne, CA
...progressive disease; • Must have recovered from any treatment-related toxicities prior to registration, except for alopecia, grade 1 fatigue, or grade 1 neurotoxicity; • A current cigarette smoker (minimum of 10 cigarettes ...
View Page

17.  Study Posting (4259) Trial #87798, Lung Cancer, La Verne, CA
...progressive disease; • Must have recovered from any treatment-related toxicities prior to registration, except for alopecia, grade 1 fatigue, or grade 1 neurotoxicity; • A current cigarette smoker (minimum of 10 cigarettes ...
View Page

18.  CenterWatch Clinical Research Profile (5132) Trial #2090, DermResearch, Inc., Austin, TX
...indications • Women's health • Pharmacokinetics including overnight facility • Neurology • Vaccines Dermatology • Acne • Actinic Keratosis • Androgenetic Alopecia • Atopic Dermatitis/Eczema • Bacterial Skin Infections • Basal Cell Carcinoma • Hand Dermatitis • Herpes Labialis • Genital Herpes ...
View Page

19. Clinical Trial Results by Drug Names
...frequently observed AEs were diarrhea (70%), rash (55%), nausea (40%), dry skin (32%), dyspnea (28%), alopecia (26%) and anorexia (26%). The most frequently observed Tarceva-related AEs were diarrhea (62%), rash (55%), dry skin (32%), acne (28%), nausea (23%), alopecia (21%) and pruritus (17%). Most treatment-related AEs were of grade 1-2 intensity; 7 ...
View Page

20. Clinical Trial Results by Drug Names
...each agent. The most commonly reported adverse events, irrespective of relationship to study treatment, were alopecia, nail disorders, constipation, lymphopenia, hyperglycemia, and elevated lactate dehydrogenase concentrations. Diarrhea and hand-foot syndrome ...
...congestive heart failure, hypertension, or wound-healing disorders. The most frequent severe adverse events were alopecia, polyneuropathy, neutropenia, stomatitis, fatigue, and leukopenia. The remaining severe adverse events each occurred in only ...
View Page